Conavi Medical Corp. (TSXV:CNVI)
Canada · Delayed Price · Currency is CAD 0.1800
-0.0100 (-5.26%)
Aug 20, 2026, 3:56 PM EST
Conavi Medical Cash Flow Statement
Financials in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Net Income | -17.85 | -20.52 | -43.62 | -26.09 | -11.87 |
Depreciation & Amortization | 0.67 | 0.74 | 0.89 | 1.17 | 0.93 |
Other Amortization | 0.1 | 0.07 | 0.09 | 0.12 | 0.16 |
Loss (Gain) From Sale of Assets | 0.11 | 0.2 | 0.2 | 0.19 | 0.03 |
Asset Writedown & Restructuring Costs | -0.09 | 0.04 | 0.09 | 0.03 | 0.06 |
Loss (Gain) From Sale of Investments | - | - | - | -0.13 | - |
Stock-Based Compensation | 0.93 | 0.44 | 0.26 | 0.62 | 1.18 |
Other Operating Activities | -1.6 | -2.42 | 17.39 | 3 | -0.03 |
Change in Accounts Receivable | 0.1 | 0.69 | 0.06 | -0.5 | 0.04 |
Change in Inventory | 0.06 | 1.27 | 1.39 | -0.04 | -0.23 |
Change in Accounts Payable | -1.6 | -4.84 | 2.45 | 1.92 | 0.19 |
Change in Unearned Revenue | - | - | - | 0.18 | 0.02 |
Change in Other Net Operating Assets | -4.17 | -0.79 | 0.63 | -0.63 | -0.33 |
Operating Cash Flow | -23.68 | -25.1 | -20.15 | -19.98 | -8.85 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Capital Expenditures | -0.05 | -0.07 | -0.58 | -0.69 | -0.93 |
Sale (Purchase) of Intangibles | -0.31 | -0.11 | -0.27 | -0.14 | -0.16 |
Investment in Securities | - | - | - | 0.13 | - |
Other Investing Activities | - | 3.75 | - | - | - |
Investing Cash Flow | -0.36 | 3.57 | -0.85 | -0.69 | -1.09 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Short-Term Debt Issued | - | - | 8.19 | - | - |
Long-Term Debt Issued | - | - | - | 0.41 | - |
Total Debt Issued | - | - | 8.19 | 0.41 | - |
Long-Term Debt Repaid | - | -1.53 | -0.94 | -1.43 | -0.95 |
Net Debt Issued (Repaid) | -1.71 | -1.53 | 7.26 | -1.02 | -0.95 |
Issuance of Common Stock | 22.91 | 22.16 | 0.01 | 0 | - |
Other Financing Activities | 6.3 | 6.3 | - | - | - |
Financing Cash Flow | 27.5 | 26.94 | 7.26 | 30.25 | 12.98 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Net Cash Flow | 3.46 | 5.41 | -13.73 | 9.58 | 3.04 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Free Cash Flow | -23.74 | -25.17 | -20.72 | -20.66 | -9.78 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -3050.90% | -275.96% | -958.95% | -874.07% | -362.22% |
Free Cash Flow Per Share | -0.29 | -0.44 | -3.36 | -3.36 | -1.59 |
Levered Free Cash Flow | -18.43 | -14.68 | -16.88 | -14.69 | - |
Unlevered Free Cash Flow | -17.84 | -7.38 | -11.87 | -11.16 | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Change in Working Capital | -5.95 | -3.66 | 4.55 | 1.11 | 0.69 |